BVAXF
Price
$0.05
Change
-$0.00 (-0.00%)
Updated
Dec 20 closing price
SEPSF
Price
$0.03
Change
-$0.02 (-40.00%)
Updated
Dec 18 closing price
Ad is loading...

BVAXF vs SEPSF

Header iconBVAXF vs SEPSF Comparison
Open Charts BVAXF vs SEPSFBanner chart's image
BioVaxys Technology
Price$0.05
Change-$0.00 (-0.00%)
Volume$1.11M
CapitalizationN/A
ASEP Medical Holdings
Price$0.03
Change-$0.02 (-40.00%)
Volume$10.02K
CapitalizationN/A
BVAXF vs SEPSF Comparison Chart
Loading...
BVAXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SEPSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BVAXF vs. SEPSF commentary
Dec 24, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BVAXF is a Hold and SEPSF is a Hold.

COMPARISON
Comparison
Dec 24, 2024
Stock price -- (BVAXF: $0.05 vs. SEPSF: $0.03)
Brand notoriety: BVAXF and SEPSF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BVAXF: 208% vs. SEPSF: 68%
Market capitalization -- BVAXF: $11.9M vs. SEPSF: $2.95M
BVAXF [@Biotechnology] is valued at $11.9M. SEPSF’s [@Biotechnology] market capitalization is $2.95M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BVAXF’s FA Score shows that 0 FA rating(s) are green whileSEPSF’s FA Score has 1 green FA rating(s).

  • BVAXF’s FA Score: 0 green, 5 red.
  • SEPSF’s FA Score: 1 green, 4 red.
According to our system of comparison, BVAXF is a better buy in the long-term than SEPSF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BVAXF’s TA Score shows that 5 TA indicator(s) are bullish while SEPSF’s TA Score has 3 bullish TA indicator(s).

  • BVAXF’s TA Score: 5 bullish, 5 bearish.
  • SEPSF’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, BVAXF is a better buy in the short-term than SEPSF.

Price Growth

BVAXF (@Biotechnology) experienced а +11.76% price change this week, while SEPSF (@Biotechnology) price change was -49.64% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.15%. For the same industry, the average monthly price growth was -2.89%, and the average quarterly price growth was +3.31%.

Industries' Descriptions

@Biotechnology (-2.15% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BVAXF($11.9M) has a higher market cap than SEPSF($2.95M). BVAXF YTD gains are higher at: 15.854 vs. SEPSF (-84.320). SEPSF has higher annual earnings (EBITDA): -4.22M vs. BVAXF (-5.67M). SEPSF has higher revenues than BVAXF: SEPSF (244K) vs BVAXF (0).
BVAXFSEPSFBVAXF / SEPSF
Capitalization11.9M2.95M403%
EBITDA-5.67M-4.22M134%
Gain YTD15.854-84.320-19%
P/E RatioN/AN/A-
Revenue0244K-
Total CashN/A12.3K-
Total DebtN/A22.2K-
FUNDAMENTALS RATINGS
BVAXF: Fundamental Ratings
BVAXF
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
41
Fair valued
PROFIT vs RISK RATING
1..100
94
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BVAXFSEPSF
RSI
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
38%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
17%
Momentum
ODDS (%)
Bullish Trend 4 days ago
80%
Bearish Trend 4 days ago
56%
MACD
ODDS (%)
Bullish Trend 4 days ago
76%
Bearish Trend 4 days ago
42%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
85%
Bearish Trend 4 days ago
55%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
35%
Advances
ODDS (%)
Bullish Trend 4 days ago
80%
N/A
Declines
ODDS (%)
Bearish Trend 14 days ago
90%
N/A
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
87%
Bullish Trend 4 days ago
33%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
33%
View a ticker or compare two or three
Ad is loading...
BVAXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SEPSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GREYX8.910.15
+1.71%
GuideStone Funds Global Rl Est Secs Inst
MMUKX22.540.30
+1.35%
MFS Utilities R6
HDGFX33.320.37
+1.12%
Hartford Dividend and Growth F
PZISX13.910.05
+0.36%
Pzena Small Cap Value Institutional
COSRX9.87-0.02
-0.20%
Columbia Overseas Core R

BVAXF and

Correlation & Price change

A.I.dvisor tells us that BVAXF and GSGTF have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BVAXF and GSGTF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BVAXF
1D Price
Change %
BVAXF100%
+2.15%
GSGTF - BVAXF
29%
Poorly correlated
N/A
THTX - BVAXF
24%
Poorly correlated
+7.83%
EDSA - BVAXF
21%
Poorly correlated
-1.14%
CSBR - BVAXF
21%
Poorly correlated
-0.60%
SEPSF - BVAXF
20%
Poorly correlated
N/A
More

SEPSF and

Correlation & Price change

A.I.dvisor tells us that SEPSF and VTYX have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SEPSF and VTYX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SEPSF
1D Price
Change %
SEPSF100%
N/A
VTYX - SEPSF
29%
Poorly correlated
-1.75%
CLVLF - SEPSF
25%
Poorly correlated
N/A
ALGS - SEPSF
24%
Poorly correlated
+3.89%
BVAXF - SEPSF
21%
Poorly correlated
+2.15%
ALLR - SEPSF
14%
Poorly correlated
-3.87%
More